BrainLife | Library
CNS Tumors
Diffuse astrocytic and oligodendroglial tumors
Diffuse astrocytoma


Home > Library > CNS Tumors > Diffuse astrocytic and oligodendroglial tumors > Diffuse astrocytoma



Contents



CASE REPORTS


CLASSIFICATION


DIAGNOSIS


EPIDEMIOLOGY, RISK FACTORS


ETIOLOGY, PATHOGENESIS, PATHOLOGY


FOLLOW-UP, QUALITY OF LIFE


INTEGRATIVE MEDICINE


OVERALL MANAGEMENT


PROGNOSIS


TREATMENT



Case reports



Trogrlić I, Trogrlić D, Trogrlić Z.
Treatment of progression of diffuse astrocytoma by herbal medicine: case report.
Afr J Tradit Complement Altern Med. 2016 Sep 29;13(6):1-4. doi: 10.21010/ajtcam.v13i6.1. _



Prognosis



Choi J, Kim SH, Ahn SS, et al.
Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma.
Sci Rep. 2020;10(1):2086. Published 2020 Feb 7. doi:10.1038/s41598-020-59089-x. _




Tunthanathip T, Ratanalert S, Sae-Heng S, Oearsakul T, Sakaruncchai I, Kaewborisutsakul A, Chotsampancharoen T, Intusoma U, Kitkhuandee A, Vaniyapong T.
Prognostic Factors and Nomogram Predicting Survival in Diffuse Astrocytoma.
J Neurosci Rural Pract. 2020 Jan;11(1):135-143. doi: 10.1055/s-0039-3403446. Epub 2020 Mar 3. _